Clinical Benefits The iWALK crutch is FDA-approved and clinically validated to reduce DVT risk, improve blood flow, and decrease venous stasis, which can be a compelling differentiator when engaging with medical professionals and rehabilitation centers seeking evidence-based mobility solutions.

Patient Preference With 90% of users preferring the iWALK due to hands-free mobility and maintenance of daily routines, sales pitches can emphasize patient satisfaction and adherence to rehabilitation protocols to drive adoption among physicians, clinics, and payers.

Endorsements & Visibility Endorsements from surgeons, professional athletes, dancers, and other high-visibility figures can be leveraged to build credibility with orthopedic clinics, sports medicine facilities, and rehab centers seeking reliable, patient-friendly mobility aids.

Market Positioning As a hands-free, mobility-focused alternative to traditional crutches, iWALK targets non-weight-bearing lower-leg conditions and post-injury rehabilitation, suggesting opportunities with orthopedic distributors, physical therapy networks, and hospital supply channels.

Growth Signals With revenue in the low-to-mid seven-figure range and a small team, there is potential to scale through partnerships with larger medical device distributors, enlisting clinics and athletic organizations, and expanding digital marketing to reach rehab facilities and sports medicine programs.